BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pushko P, Lukashevich IS, Weaver SC, Tretyakova I. DNA-launched live-attenuated vaccines for biodefense applications. Expert Rev Vaccines 2016;15:1223-34. [PMID: 27055100 DOI: 10.1080/14760584.2016.1175943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen T, Zhu S, Wei N, Zhao Z, Niu J, Si Y, Cao S, Ye J. Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection. Viruses 2022;14:1121. [DOI: 10.3390/v14061121] [Reference Citation Analysis]
2 Tretyakova I, Tomai M, Vasilakos J, Pushko P. Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits. Front Trop Dis 2022;3:813671. [DOI: 10.3389/fitd.2022.813671] [Reference Citation Analysis]
3 Hansen CA, Barrett ADT. The Present and Future of Yellow Fever Vaccines. Pharmaceuticals (Basel) 2021;14:891. [PMID: 34577591 DOI: 10.3390/ph14090891] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Chin WX, Lee RCH, Kaur P, Lew TS, Yogarajah T, Kong HY, Teo ZY, Salim CK, Zhang RR, Li XF, Alonso S, Qin CF, Chu JJH. A single-dose live attenuated chimeric vaccine candidate against Zika virus. NPJ Vaccines 2021;6:20. [PMID: 33514743 DOI: 10.1038/s41541-021-00282-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Szurgot I, Ljungberg K, Kümmerer BM, Liljeström P. Infectious RNA vaccine protects mice against chikungunya virus infection. Sci Rep 2020;10:21076. [PMID: 33273501 DOI: 10.1038/s41598-020-78009-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sharma S, Schmid MA, Sanchez Felipe L, Grenelle J, Kaptein SJF, Coelmont L, Neyts J, Dallmeier K. Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Hum Vaccin Immunother 2020;16:2196-203. [PMID: 32574095 DOI: 10.1080/21645515.2020.1765621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Stromberg ZR, Fischer W, Bradfute SB, Kubicek-Sutherland JZ, Hraber P. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses. Vaccines (Basel) 2020;8:E273. [PMID: 32503232 DOI: 10.3390/vaccines8020273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Tretyakova I, Plante KS, Rossi SL, Lawrence WS, Peel JE, Gudjohnsen S, Wang E, Mirchandani D, Tibbens A, Lamichhane TN, Lukashevich IS, Comer JE, Weaver SC, Pushko P. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge. Vaccine 2020;38:3378-86. [PMID: 32085953 DOI: 10.1016/j.vaccine.2020.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Kleinert RDV, Montoya-Diaz E, Khera T, Welsch K, Tegtmeyer B, Hoehl S, Ciesek S, Brown RJP. Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus. Viruses 2019;11:E960. [PMID: 31627415 DOI: 10.3390/v11100960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Wong SH, Jassey A, Wang JY, Wang WC, Liu CH, Lin LT. Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family. Vaccines (Basel) 2019;7:E123. [PMID: 31547131 DOI: 10.3390/vaccines7040123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Tretyakova I, Tibbens A, Jokinen JD, Johnson DM, Lukashevich IS, Pushko P. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome. Vaccine 2019;37:3317-25. [PMID: 31072736 DOI: 10.1016/j.vaccine.2019.04.072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 Agnihothram S, Menachery VD, Yount BL Jr.,, Lindesmith LC, Scobey T, Whitmore A, Schäfer A, Heise MT, Baric RS. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform. J Virol 2018;92:e00027-18. [PMID: 29540599 DOI: 10.1128/JVI.00027-18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
13 Nickols B, Tretyakova I, Tibbens A, Klyushnenkova E, Pushko P. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice. Virology 2017;512:66-73. [PMID: 28938099 DOI: 10.1016/j.virol.2017.09.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
14 Peeters B, de Leeuw O. A single-plasmid reverse genetics system for the rescue of non-segmented negative-strand RNA viruses from cloned full-length cDNA. J Virol Methods 2017;248:187-90. [PMID: 28743584 DOI: 10.1016/j.jviromet.2017.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]